Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Eye In The Sky: GE Healthcare’s Dynamic Crisis Management Can Be Replicated In ‘Normal Times’

Software-based hospital load-balancing tool proves its value during COVID-19 emergency

Executive Summary

Real-time decision support came of age in dramatic style during COVID-19. GE Healthcare’s CEO of Clinical Command Centers Jeff Terry explains that AI- and app-based health system collaboration and virtualized care will become increasingly embedded as health care delivery transforms.

You may also be interested in...



Healthcare Reform: GE HealthCare On ‘Building A Bridge To The Future State’

System interoperability and building trust in AI capabilities are central to the strategic collaboration and organic growth plans at GE HealthCare, according to US and Canada regional president and CEO Catherine Estrampes, who spoke to In Vivo as the company released the findings of a major survey of clinicians and patients on future healthcare system needs.

Spinning To Be Agile: GE Healthcare’s Precision Health Ambition Majors On Lean

Incoming president and CEO Peter Arduini laid out a path towards an agile future that exploits the ‘power of lean’ for GE Healthcare, ahead of the division’s 2023 spin off as a separate company.

Spinning To Be Agile: GE Healthcare’s Precision Health Ambition Majors On Lean

Incoming president and CEO Peter Arduini laid out a path towards an agile future that exploits the ‘power of lean’ for GE Healthcare, ahead of the division’s 2023 spin off as a separate company.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142660

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel